Results 101 to 110 of about 645 (152)

General practitioners' perspectives on diagnosis and treatment of uncomplicated urinary tract infections: A qualitative study in the Northern Dutch-German cross-border region. [PDF]

Eur J Gen Pract
Bedri A, Mulderij-Jansen V, Aits I, Berends M, Freitag MH, van der Worp H, Glasner C, Blanker MH.   +7 more
europepmc   +1 more source

Antibiotic resistance of urinary pathogens after kidney transplantation: a 10-year single-center survey in Germany. [PDF]

Infection
Weber P, Braß P, Jäger J, Jacquet L, Jansen S, Gäckler A, Jürgens C, Reinold J, Eisenberger U, Rath PM, Kribben A, Witzke O, Rohn H.   +12 more
europepmc   +1 more source

Decoding antibiotic modes of action from multimodal cellular responses

Sieber S, Hesse J, Schum D, Leidel L, Gareis L, Herrmann J, Mueller R.   +6 more
europepmc   +1 more source

One-step drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly

Luisi B, Du D, Chao Y, Zhong Z, Maimaiti T, Jackson M, Dong R, Gao X, Guo J, Li S, Shang W, Liu H, Jiang H, Zhang S, Zhao H, Ouyang Q.   +15 more
europepmc   +1 more source

Antifungal activity of nitroxoline against Candida auris isolates [PDF]

Clinical Microbiology and Infection, 2021
To investigate the in vitro activity of nitroxoline against a molecularly characterized collection of clinical Candida auris isolates.Thirty-five clinical isolates of C. auris from diverse sources representing all five different C. auris clades were included in the study. Nitroxoline activity was assessed using broth microdilution.
Frieder Fuchs, Oliver Kurzai, Axel Hamprecht   +2 more
exaly   +4 more sources

Antimicrobial activity of clioquinol and nitroxoline: a scoping review

Archives of Microbiology, 2022
Clioquinol and nitroxoline, two drugs with numerous pharmacological properties fallen into disuse for many decades. The first was considered dangerous due to contraindications and the second mainly because was taken as ineffective, despite its known antibacterial activity. In the last decades, the advances in pharmaceutical chemistry, molecular biology,
Saulo Andrade, Alexandre Fuentefria, Fuentefria Alexandre Meneghello   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Analysis of pharmacopoeia nitroxoline

Pharmaceutical Chemistry Journal, 1978
I I Dozorova, V G Voronin, Voronin V G
exaly   +2 more sources

Repurposing of Nitroxoline Drug for the Prevention of Neurodegeneration

Chemical Research in Toxicology, 2019
Oxidative stress has been documented as one of the significant causes of neurodegenerative diseases. Therefore, antioxidant therapy for the prevention of neurodegenerative diseases seems to be an interesting strategy in drug discovery. The quinoline-based compound, namely 5-nitro-8-quinolinol (NQ), has shown excellent antimicrobial, anticancer, and ...
Truong Van Hau, Waralee Ruankham, Wilasinee Suwanjang, Napat Songtawee, Prapimpun Wongchitrat, Ratchanok Pingaew, Virapong Prachayasittikul, Supaluk Prachayasittikul, Kamonrat Phopin   +8 more
openaire   +2 more sources

Antibacterial and Antifungal Activities of Nitroxoline Mannich Bases

Chemotherapy, 2009
The in vitro activity of nitroxoline and its Mannich bases against bacteria and fungi was investigated. Nitroxoline and its derivative with diisopropylamine as an amino component, exhibited the highest antimicrobial activity. The optimum hydro/lipophilic properties (log P), both for antibacterial and antifungal activity, are about log P values of 2 ...
Medić-Šarić, Marica, Maysinger, Dušica, Movrin Marija, Dvoržak, I.   +3 more
openaire   +3 more sources